SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Patent production is a prerequisite for successful exit of a biopharmaceutical company
4 references·0 citing·20 second hop
Patent production is a prerequisite for successful exit of a biopharmaceutical company (2015)Patent production is a prerequisite for s…RETRACTED: The role of corporate technology strategy and patent portfolios in low-, medium- and high-technology firms (2008)RETRACTED: The role of corpor…How many patents does a biopharmaceutical company need? (2008)How many patents does a bioph…Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains (2007)Vertical alliance networks: T…The impact of firmspecific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry (1997)The impact of firmspecific ca…Building Global Biobrands: Taking Biotechnology to Market (2003)A New Trade Framework for Global Healthcare R&D (2004)Insights into US public biotech sector using patenting trends (2006)The Market for "Lemons": Quality Uncertainty and the Market Mechanism (1970)Job Market Signaling (1973)Absorptive Capacity: A New Perspective on Learning and Innovation (1990)The impact of stocks and flows of organizational knowledge on firm performance: an empirical investigation of the biotechnology industry (1999)The Reification of Absorptive Capacity: A Critical Review and Rejuvenation of the Construct (2006)Is innovation always beneficial? A meta-analysis of the relationship between innovation and performance in SMEs (2010)The Strength of Weak Ties (1973)Structural Holes: The Social Structure of Competition (1995)Interorganizational Collaboration and the Locus of Innovation: Networks of Learning in Biotechnology (1996)Building Dynamic Capabilities: Innovation Driven by Individual-, Firm-, and Network-Level Effects (2007)Internationalization, innovation and entrepreneurship: business models for new technology-based firms (2010)The impact of technological relatedness, prior ties, and geographical distance on university–industry collaborations: A joint-patent analysis (2011)Case Study Research: Design and Methods (1984)Qualitative Data Analysis: An Expanded Sourcebook (1994)A Capability‐Based Framework for Open Innovation: Complementing Absorptive Capacity (2009)You can’t manage right what you can’t measure well: Technological innovation efficiency (2013)The digital transformation of business models in the creative industries: A holistic framework and emerging trends (2018)
this work references cited by second hop

References

  • 1997The impact of firmspecific capabilities on the amount of capital raised in an initial public offering: Evidence from the biotechnology industry371 cited
  • 2007Vertical alliance networks: The case of university–biotechnology–pharmaceutical alliance chains300 cited
  • 2008RETRACTED: The role of corporate technology strategy and patent portfolios in low-, medium- and high-technology firms48 cited
  • 2008How many patents does a biopharmaceutical company need?9 cited

Cited by

No citing works inside the corpus for this window.

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work